This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use

Cheng-Yi Huang, MD 

Published: September 21, 2022


Using data from the Taiwan National Health Insurance Research Database, Cheng-Yi Huang, MD, explains how he and Su-Chen Fang, PhD, and Yu-Hsuan Joni Shao, PhD, compared long-term effectiveness of switching to long-acting injectable antipsychotics versus remaining on oral antipsychotics. 

Read the Full Article

Watch the Mandarin version.

Quick Links: Schizophrenia and Schizoaffective Disorders


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Generalizability of the Results of Efficacy Trials in First-Episode Schizophrenia: Comparing Outcome and Study Discontinuation of Groups of Participants in the Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial

First-episode schizophrenia patients with suicidal ideation and substance use disorder are often excluded from clinical trials. Omitting...